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The present study was designed to investigate the possible hepatoprotective effect of 
berberine (BBR) nano micelles on liver cirrhosis induced by bile duct ligation model 
(BDL) in male rats. 
Introduction: The anti-fibrotic effect of chronic berberine (BBR) had previously 
demonstrated in a rat model of bile duct ligation (BDL) - induced liver fibrosis. As a 
result, the aim of present study was to investigate the possible hepatoprotective 
effect of BBR nanomicelles on liver cirrhosis induced by Bile duct ligation model 
(BDL) in male rats. 
Methods and Results: Male Wistar rats were divided into 7 groups (n= 6) including 
sham-operated, BDL + saline, BDL + nanoBBR (50 mg/kg, p.o.), BDL + 
nanomicelles, BDL + BBR (50 and 100 mg/kg, p.o.), BDL + silymarin (100 mg/kg, 
p.o.). After 21 days of drugs' treatments following bile duct ligateation, the serum 
and tissue levels of some hepatic markers were measured and pathologic evaluations 
performed.BDL could markedly increase aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), and total bilirubin (TBIL) serum levels and tissue tumor 
necrosis factor-alpha (TNF-α), level along with reductions in tissue levels of 
glutathione (GSH), superoxide dismutase (SOD) and total protein levels. On the 
other hand, BBR nanomicelles (50 mg/kg, p.o.) and silymarin (100 mg/kg, p.o.) 
markedly decreased the serum levels of AST and ALT while enhanced GSH level. 
In addition, BBR nanomicelles (50 mg/kg, p.o.), silymarin (100 mg/kg, p.o.) and 
BBR (100 mg/kg, p.o.) groups showed a considerable increase in SOD levels. BBR 
nanomicelles (50 mg/kg, p.o.) significantly lowered TNF-α level. In addition, 
nanoBBR group prevented liver cirrhosis in histopathologic analysis. 
 Conclusions:Therefore, formulation of BBR nanomicelles may represent a good 
approach to enhance the effect of BBR in liver injuries. 
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